BioXcel Therapeutics, Inc.(BTAI)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | Yocca Frank Chief Scientific Officer | Sale | -6,845 | -20.73%26,175 | $1.08 | $7,427 | View SEC filing | |
| 2026-05-22 | Rodriguez Javier See Remarks | Sale | -6,560 | -6.39%96,025 | $1.08 | $7,111 | View SEC filing | |
| 2026-05-22 | Steinhart Richard I Chief Financial Officer | Sale | -6,845 | -20.65%26,300 | $1.08 | $7,427 | View SEC filing | |
| 2026-05-22 | Mehta Vimal CEO and President | Sale | -19,419 | -0.22%8,894,441 | $1.09 | $21,108 | View SEC filing | |
| 2024-12-17 | O'Neill Vincent See Remarks | Sale | -165 | -0.82%19,957 | $0.35 | $58 | View SEC filing | |
| 2024-12-17 | Mehta Vimal CEO and President | Sale | -3,117 | -0.03%8,913,860 | $0.36 | $1,131 | View SEC filing | |
| 2024-12-17 | Steinhart Richard I Chief Financial Officer | Sale | -577 | -2.68%20,932 | $0.36 | $207 | View SEC filing | |
| 2024-12-17 | Rodriguez Javier See Remarks | Sale | -430 | -0.42%102,585 | $0.36 | $153 | View SEC filing | |
| 2024-12-17 | Yocca Frank Chief Scientific Officer | Sale | -430 | -1.46%28,931 | $0.35 | $152 | View SEC filing | |
| 2024-10-03 | Wiley Matthew T. Chief Commercial Officer | Sale | -6,272 | -24.81%19,011 | $0.55 | $3,450 | View SEC filing | |
| 2024-10-03 | Rodriguez Javier See Remarks | Sale | -6,863 | -22.40%23,770 | $0.55 | $3,775 | View SEC filing | |
| 2024-10-03 | Yocca Frank Chief Scientific Officer | Sale | -7,175 | -20.24%28,278 | $0.55 | $3,946 | View SEC filing | |
| 2024-10-03 | Steinhart Richard I Chief Financial Officer | Sale | -7,175 | -26.13%20,279 | $0.55 | $3,946 | View SEC filing | |
| 2024-10-03 | O'Neill Vincent See Remarks | Sale | -5,556 | -22.09%19,601 | $0.55 | $3,056 | View SEC filing | |
| 2024-09-17 | Yocca Frank Chief Scientific Officer | Sale | -355 | -2.44%14,203 | $0.69 | $245 | View SEC filing | |
| 2024-09-17 | Mehta Vimal CEO and President | Sale | -1,982 | -0.03%7,739,167 | $0.69 | $1,367 | View SEC filing | |
| 2024-09-17 | Steinhart Richard I Chief Financial Officer | Sale | -356 | -5.43%6,204 | $0.69 | $246 | View SEC filing | |
| 2024-09-17 | Rodriguez Javier See Remarks | Sale | -345 | -3.64%9,133 | $0.69 | $238 | View SEC filing | |
| 2024-09-17 | O'Neill Vincent See Remarks | Sale | -138 | -3.41%3,907 | $0.69 | $95 | View SEC filing | |
| 2024-09-17 | Wiley Matthew T. Chief Commercial Officer | Sale | -215 | -5.06%4,033 | $0.69 | $149 | View SEC filing | |
| 2024-06-18 | Yocca Frank Chief Scientific Officer | Sale | -372 | -2.69%13,474 | $1.28 | $476 | View SEC filing | |
| 2024-06-18 | Wiley Matthew T. Chief Commercial Officer | Sale | -244 | -6.52%3,498 | $1.26 | $308 | View SEC filing | |
| 2024-06-18 | Steinhart Richard I Chief Financial Officer | Sale | -372 | -6.36%5,476 | $1.26 | $470 | View SEC filing | |
| 2024-06-18 | Rodriguez Javier See Remarks | Sale | -361 | -4.12%8,394 | $1.26 | $456 | View SEC filing | |
| 2024-06-18 | O'Neill Vincent See Remarks | Sale | -155 | -4.21%3,524 | $1.29 | $199 | View SEC filing |
1-25 of 79